AGEs control article,晚期糖基化終末產物蛋白對照品其他優質產品：
大鼠甲基化酶(Methylase)試劑盒說明書，96T/48T優惠
大鼠抗增殖細胞核抗原抗體(PCNA)試劑盒說明書，96T/48T優惠
大鼠脂蛋白脂酶(LPL)試劑盒說明書，96T/48T優惠
大鼠抗酒石酸酸性磷酸酶5b(TRACP-5b)試劑盒說明書，96T/48T優惠
大鼠葡萄糖依賴性胰島素釋放多肽(GIP)試劑盒說明書，96T/48T優惠
大鼠糖原磷酸化酶同工酶II(GP-II)試劑盒說明書，96T/48T優惠
大鼠糖原磷酸化酶同工酶MM(GP-MM)試劑盒說明書，96T/48T優惠
大鼠糖原磷酸化酶同工酶BB(GP-BB)試劑盒說明書，96T/48T優惠
大鼠甲狀腺素抗體(TAb)試劑盒說明書，96T/48T優惠
大鼠抗促甲狀腺素受體抗體(TRAb)試劑盒說明書，96T/48T優惠
AGEs control article,晚期糖基化終末產物蛋白對照品產品詳情：
英文名稱：AGEs control article(advanced glycosylation end products control article) Protein
中文名稱：晚期糖基化終末產物蛋白對照品
產品編號：bys-1158PC
規 格：50mg 100mg
多肽活性：
產品來源：
分 類：
偶聯蛋白：
純化方法：
儲 存 液：0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
相關產品：
Anti-DTNBP1 (Dysbindin-1) 精神分裂癥易感基因抗體
Anti-dUTPase(deoxyuridine triphosphate nucleotedohydrolase) 抗脫氧*三磷酸核苷水解酶抗體
Anti-DVH(Duck viral hepatitis) 鴨病毒性肝炎抗體
Anti-DPV(Duck plague virus) 抗鴨瘟病毒抗體
Anti-DP-I/DSP(desmoplakinⅠ) 抗橋粒斑蛋白1抗體
Anti-DPⅡ (desmoplakinⅡ) 抗橋粒斑蛋白2抗體
Anti-DVL1 (dishevelled 1) 蓬亂蛋白1抗體
Anti-Brucella．spp 抗布魯氏菌抗體
Anti-Dynamin 2 鼠抗人鳥苷三磷酸酶－發動蛋白2單克隆抗體
Anti-Dynamin 2 兔抗人、大、小鼠鳥苷三磷酸酶發動蛋白2抗體
保存條件：Store at -20 °C for one year. The lyophilized powder is stable at room temperature for at least one month and for greater than a year when kept at -20°C. Upon reconstituted, aliquot and store at -20°C or -80°C. Avoid repeated freeze/thaw cycles.
產品介紹：Advanced Glycation End products (AGEs) are the result of a chain of chemical reactions after an initial glycation reaction. The intermediate products are known, variously, as Amadori, Schiff base and Maillard products, named after the researchers who first described them. (The literature is inconsistent in applying these terms. For example, Maillard reaction products are sometimes considered intermediates and sometimes end products.) Side products generated in intermediate steps may be oxidizing agents (such as hydrogen peroxide), or not (such as beta amyloid proteins).[1] "Glycosylation" is sometimes used for "glycation" in the literature, usually as 'non-enzymatic glycosylation. The AGE modified BSA was produced by reacting BSA with glycolaldehyde under sterile conditions followed by extensive dialysis and purification steps
